IL134068A0 - Mammalian cytokine: interleukin-b30 and related reagents - Google Patents

Mammalian cytokine: interleukin-b30 and related reagents

Info

Publication number
IL134068A0
IL134068A0 IL13406898A IL13406898A IL134068A0 IL 134068 A0 IL134068 A0 IL 134068A0 IL 13406898 A IL13406898 A IL 13406898A IL 13406898 A IL13406898 A IL 13406898A IL 134068 A0 IL134068 A0 IL 134068A0
Authority
IL
Israel
Prior art keywords
interleukin
related reagents
mammalian cytokine
cytokine
mammalian
Prior art date
Application number
IL13406898A
Other languages
English (en)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25413278&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL134068(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of IL134068A0 publication Critical patent/IL134068A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL13406898A 1997-07-25 1998-07-24 Mammalian cytokine: interleukin-b30 and related reagents IL134068A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90090597A 1997-07-25 1997-07-25
PCT/US1998/015423 WO1999005280A1 (en) 1997-07-25 1998-07-24 Mammalian cytokine: interleukin-b30 and related reagents

Publications (1)

Publication Number Publication Date
IL134068A0 true IL134068A0 (en) 2001-04-30

Family

ID=25413278

Family Applications (3)

Application Number Title Priority Date Filing Date
IL13406898A IL134068A0 (en) 1997-07-25 1998-07-24 Mammalian cytokine: interleukin-b30 and related reagents
IL134068A IL134068A (en) 1997-07-25 2000-01-16 Mammalian cytokine: interleukin - b 30 and isolated polunucleotides encoding the same
IL205765A IL205765A (en) 1997-07-25 2010-05-13 Unique antibody-binding polypeptide containing interleukin b-30 variant and its pharmacokinetic composition

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL134068A IL134068A (en) 1997-07-25 2000-01-16 Mammalian cytokine: interleukin - b 30 and isolated polunucleotides encoding the same
IL205765A IL205765A (en) 1997-07-25 2010-05-13 Unique antibody-binding polypeptide containing interleukin b-30 variant and its pharmacokinetic composition

Country Status (28)

Country Link
EP (3) EP2100959B1 (pl)
JP (5) JP4316133B2 (pl)
KR (1) KR100666835B1 (pl)
CN (2) CN101851286A (pl)
AR (2) AR017510A1 (pl)
AT (1) ATE443142T1 (pl)
AU (1) AU741046B2 (pl)
BR (1) BR9811039A (pl)
CA (1) CA2296272C (pl)
CO (1) CO4810232A1 (pl)
CZ (1) CZ300958B6 (pl)
DE (1) DE69841161D1 (pl)
DK (2) DK2100959T3 (pl)
ES (2) ES2331762T3 (pl)
HU (1) HU230629B1 (pl)
ID (1) ID28114A (pl)
IL (3) IL134068A0 (pl)
LT (1) LT2100959T (pl)
MY (1) MY157028A (pl)
NO (1) NO329329B1 (pl)
NZ (1) NZ502391A (pl)
PE (1) PE20000183A1 (pl)
PL (1) PL197150B1 (pl)
PT (2) PT2100959T (pl)
SK (1) SK287198B6 (pl)
TW (1) TWI237057B (pl)
WO (1) WO1999005280A1 (pl)
ZA (1) ZA986596B (pl)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6060284A (en) 1997-07-25 2000-05-09 Schering Corporation DNA encoding interleukin-B30
US6610515B1 (en) * 1997-10-23 2003-08-26 Nippon Institute For Biological Science Feline granulocyte colony-stimulating factor
AU2661199A (en) * 1998-02-06 1999-08-23 Schering Corporation Mammalian receptor proteins; related reagents and methods
WO1999054357A1 (en) * 1998-04-14 1999-10-28 Chugai Research Institute For Molecular Medicine, Inc. Novel cytokine-like protein
EP1905832A3 (en) 1999-09-09 2009-09-09 Schering Corporation Mammalian interleukin-12 P40 and interleukin B30, combinations thereof, antibodies, uses in pharmaceutical compositions
AU2005202420B2 (en) * 1999-09-09 2008-08-07 Merck Sharp & Dohme Corp. Mammalian cytokines; related reagents and methods
CA2388562C (en) * 1999-09-09 2014-07-22 Schering Corporation Mammalian cytokines; related reagents and methods
US7090847B1 (en) 1999-09-09 2006-08-15 Schering Corporation Mammalian cytokines; related reagents and methods
US7510709B2 (en) 2002-10-30 2009-03-31 Genentech, Inc. Method of treating inflammatory disease by inhibition of IL-17 production
EP1623011B1 (en) 2003-05-09 2013-01-02 Janssen Biotech, Inc. Il-23p40 specific immunoglobulin derived proteins, compositions, methods and uses
WO2005108425A1 (en) * 2004-05-10 2005-11-17 Cytos Biotechnology Ag Il-23 p19 antigen array and uses thereof
AR051444A1 (es) 2004-09-24 2007-01-17 Centocor Inc Proteinas derivadas de inmunoglobulina especifica de il-23p40, composiciones, epitopos, metodos y usos
AU2006265002B2 (en) 2005-06-30 2012-09-20 Centocor, Inc. Anti-IL-23 antibodies, compositions, methods and uses
SI1971366T1 (sl) 2005-12-29 2014-10-30 Janssen Biotech, Inc. Humana protitelesa anti-il-23, sestavki, postopki in uporabe
US7910703B2 (en) 2006-03-10 2011-03-22 Zymogenetics, Inc. Antagonists to IL-17A, IL-17F, and IL-23P19 and methods of use
JP2009540018A (ja) 2006-06-13 2009-11-19 ザイモジェネティクス， インコーポレイテッド Ｉｌ−１７およびｉｌ−２３アンタゴニストならびにその使用方法
TWI426918B (zh) 2007-02-12 2014-02-21 Merck Sharp & Dohme Ｉｌ-２３拮抗劑於治療感染之用途
EP2220120A2 (en) 2007-11-27 2010-08-25 Ablynx N.V. Amino acid sequences directed against heterodimeric cytokines and/or their receptors and polypeptides comprising the same
SG10201608871XA (en) 2008-05-05 2016-12-29 Novimmune Sa Anti-il-17a/il-17f cross-reactive antibodies and methods of use thereof
CA2759848C (en) 2009-05-05 2018-12-04 Novimmune S.A. Anti-il-17f antibodies and methods of use thereof
JO3244B1 (ar) 2009-10-26 2018-03-08 Amgen Inc بروتينات ربط مستضادات il – 23 البشرية
PE20141162A1 (es) 2010-11-04 2014-09-18 Boehringer Ingelheim Int Anticuerpos anti-il-23
EP4039275A1 (en) 2012-05-03 2022-08-10 Boehringer Ingelheim International GmbH Anti-il-23p19 antibodies
KR20150128859A (ko) 2013-03-15 2015-11-18 암젠 인크 항-il23 항체를 사용하여 크론병을 치료하는 방법
EP2968488A1 (en) 2013-03-15 2016-01-20 Amgen Inc. Methods for treating psoriasis using an anti-il-23 antibody
EP3172339A1 (en) 2014-07-24 2017-05-31 Boehringer Ingelheim International GmbH Biomarkers useful in the treatment of il-23a related diseases
UA123624C2 (uk) 2014-09-03 2021-05-05 Бьорінґер Інґельхайм Інтернаціональ Ґмбх Сполука, специфічна до іл-23а та фнп-альфа, та її застосування
CN107206081A (zh) 2015-02-04 2017-09-26 勃林格殷格翰国际有限公司 治疗炎性疾病的方法
JP6909208B2 (ja) 2015-09-17 2021-07-28 アムジェン インコーポレイテッド Ｉｌ２３経路バイオマーカーを使用するｉｌ２３アンタゴニストに対する臨床応答の予測
AU2016379157A1 (en) 2015-12-22 2018-06-21 Amgen Inc. CCL20 as a predictor of clinical response to IL23-antagonists
CA3105598A1 (en) 2018-07-13 2020-01-16 Carl GOMMOLL Treating ulcerative colitis with brazikumab
MA55149A (fr) 2018-11-20 2021-09-29 Janssen Biotech Inc Procédé sûr et efficace de traitement du psoriasis avec un anticorps spécifique anti-il-23
WO2020234834A1 (en) 2019-05-23 2020-11-26 Janssen Biotech, Inc. Method of treating inflammatory bowel disease with a combination therapy of antibodies to il-23 and tnf alpha
US12577297B2 (en) 2019-09-09 2026-03-17 Boehringer Ingelheim International Gmbh Anti-IL-23p19 antibody formulations
CA3164996A1 (en) 2019-12-20 2021-06-14 Novarock Biotherapeutics, Ltd. Anti-interleukin-23 p19 antibodies and methods of use thereof
KR20230023663A (ko) 2020-05-21 2023-02-17 얀센 바이오테크 인코포레이티드 Il-23 및 tnf 알파에 대한 항체의 병용 요법으로 염증성 장질환을 치료하는 방법

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2031216A1 (de) 1969-06-19 1971-01-14 Citizen Watch Co Ltd , Tokio Tag und Datum Stellvorrichtung fur Uhren mit Kalender
US3940475A (en) 1970-06-11 1976-02-24 Biological Developments, Inc. Radioimmune method of assaying quantitatively for a hapten
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
DE3382317D1 (de) 1982-03-15 1991-07-25 Schering Corp Hybride dns, damit hergestellte bindungszusammensetzung und verfahren dafuer.
US4659678A (en) 1982-09-29 1987-04-21 Serono Diagnostics Limited Immunoassay of antigens
NZ207394A (en) 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4859609A (en) 1986-04-30 1989-08-22 Genentech, Inc. Novel receptors for efficient determination of ligands and their antagonists or agonists
US5891680A (en) * 1995-02-08 1999-04-06 Whitehead Institute For Biomedical Research Bioactive fusion proteins comprising the p35 and p40 subunits of IL-12
WO1999054357A1 (en) * 1998-04-14 1999-10-28 Chugai Research Institute For Molecular Medicine, Inc. Novel cytokine-like protein

Also Published As

Publication number Publication date
EP2100959B1 (en) 2016-12-07
HK1024932A1 (en) 2000-10-27
IL205765A0 (en) 2011-07-31
CZ300958B6 (cs) 2009-09-23
PT1002084E (pt) 2009-12-16
PE20000183A1 (es) 2000-03-11
KR20010022214A (ko) 2001-03-15
HU230629B1 (hu) 2017-04-28
PL338262A1 (en) 2000-10-09
PT2100959T (pt) 2017-01-09
CN1271387A (zh) 2000-10-25
NO20000343L (no) 2000-03-24
ES2331762T3 (es) 2010-01-14
JP4316133B2 (ja) 2009-08-19
AU741046B2 (en) 2001-11-22
ATE443142T1 (de) 2009-10-15
DE69841161D1 (de) 2009-10-29
MY157028A (en) 2016-04-15
CN101851286A (zh) 2010-10-06
ZA986596B (en) 1999-02-08
CA2296272A1 (en) 1999-02-04
AU8589498A (en) 1999-02-16
JP2010011863A (ja) 2010-01-21
EP2100959A2 (en) 2009-09-16
PL197150B1 (pl) 2008-03-31
EP2100959A3 (en) 2009-10-14
EP1002084B1 (en) 2009-09-16
EP2233574A1 (en) 2010-09-29
JP2015037405A (ja) 2015-02-26
DK2100959T3 (en) 2017-01-30
CO4810232A1 (es) 1999-06-30
CZ2000263A3 (cs) 2000-06-14
SK287198B6 (sk) 2010-03-08
LT2100959T (lt) 2017-01-10
JP2013034480A (ja) 2013-02-21
SK912000A3 (en) 2000-09-12
HUP0004019A3 (en) 2003-08-28
TWI237057B (en) 2005-08-01
JP2005323610A (ja) 2005-11-24
NO20000343D0 (no) 2000-01-24
BR9811039A (pt) 2000-08-08
WO1999005280A1 (en) 1999-02-04
ID28114A (id) 2001-05-03
EP1002084A1 (en) 2000-05-24
AR017510A1 (es) 2001-09-12
CA2296272C (en) 2012-03-13
IL205765A (en) 2015-07-30
HUP0004019A2 (en) 2001-03-28
IL134068A (en) 2010-11-30
AR086483A2 (es) 2013-12-18
JP2001511347A (ja) 2001-08-14
NZ502391A (en) 2002-12-20
KR100666835B1 (ko) 2007-01-11
ES2610483T3 (es) 2017-04-27
NO329329B1 (no) 2010-09-27
DK1002084T3 (da) 2010-01-04

Similar Documents

Publication Publication Date Title
HUP0004019A2 (en) Mammalian cytokine: interleukin-b30 and related reagents
AU7103198A (en) Mammalian cytokines; related reagents and methods
IL148300A0 (en) Mammalian cytokines; related reagents and methods
HUP0100436A3 (en) Mammalian cytokine-like polypeptide-10
GB9720148D0 (en) Gene silencing materials and methods
AU6700598A (en) Intron-mediated recombinant techniques and reagents
AU8173098A (en) Neuroprotective methods and reagents
EP1005479A4 (en) RNS INSULATION REAGENT AND METHOD
GB9705903D0 (en) VP22 Proteins and uses thereof
GB9727172D0 (en) Reagents specific for st2l and uses therefor
IL133582A0 (en) Mammalian neuro-growth factor like protein
IL126923A0 (en) Mammalian tolloid-like gene and protein
GB9701710D0 (en) Mammalian protein
IL136988A0 (en) Novel nucleic acid and polypeptide
AU1664299A (en) Autodegradable microcarriers and their use
GB9713666D0 (en) Biosensor materials and methods
GB9704162D0 (en) Assay methods and means
GB9417793D0 (en) Bioluminescence and assay reagents
PL341293A1 (en) Beta-lypothropin and application thereof
AU9786498A (en) Human receptor proteins; related reagents and methods
AU7959598A (en) Mammalian melanocortin receptors and uses
IL136693A0 (en) V196 dna and polypeptides
AU6258399A (en) Intron-mediated recombinant techniques and reagents
GB0120368D0 (en) Assays therapeutic methods and means
AU6762398A (en) Mammalian cytokine receptor